Tempest Therapeutics
TPST
78 hedge funds and large institutions have $243M invested in Tempest Therapeutics in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 25 closing their positions.
2% more capital invested
Capital invested by funds: $237M → $243M (+$5.44M)
13% less funds holding
Funds holding: 90 → 78 (-12)
19% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 21
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
71% less call options, than puts
Call options by funds: $2.04M | Put options by funds: $7.04M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.78M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.79M |
| 3 |
Goldman Sachs
New York
|
+$3.17M |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$1.48M |
| 5 |
Renaissance Technologies
New York
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$15.8M |
| 2 |
Jennison Associates
New York
|
-$9.43M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$3.43M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$3.42M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.36M |
TPST Hedge Fund Activity: Q4 2015 in Review
78 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2015, worth a combined $243M — up 2.3% from $237M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of TPST and 13 opened new positions — a net loss of 12 holders — while 21 trimmed existing stakes and 17 added.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $4.78M. The largest seller was State Street, cutting an estimated $15.8M.
- 78 institutional investors held Tempest Therapeutics (TPST) as of Q4 2015, down from 90 in Q3 2015.
- Funds reported $243M of Tempest Therapeutics stock for Q4 2015, up 2.3% quarter-over-quarter.
- 13 funds opened new Tempest Therapeutics positions in Q4 2015 and 25 closed out, a net change of -12 holders.
- The largest Tempest Therapeutics buyer in Q4 2015 was EcoR1 Capital, an estimated $4.78M added.
- The largest Tempest Therapeutics seller in Q4 2015 was State Street, an estimated $15.8M sold.
Based on aggregated 13F filings for Q4 2015.